BTG INTERNATION LIMITED v. AMNEAL PHARMACEUTICALS LLC, decided May 14, 2019, Claim Interpretation

U.S. Patent No. 8,822,438 is directed to treating cancer (pages 7-8). “Treatment” was interpreted to include eradication, removal, modification, management, or control of a tumor or primary, regional, or metastatic cancer cells or tissue and the minimization or delay of the spread of cancer (page 15). The claims, specification, and prosecution history teach that “treatment” […]

BRADIUM TECHNOLOGIES LLC v. IANCU, decided May 13, 2019, Claim Interpretation

U.S. Patent Nos. 7,908,343 and 8,924,506 are directed to retrieving large-scale images over a low bandwidth network to display the image on a limited processing power client device using parcel prioritization (pages 2-4). For the claim term “limited bandwidth communications channel,” the specification teaches limited bandwidth conditions due to low bandwidth channel or due to […]